1. Home
  2. BEEM vs RNAZ Comparison

BEEM vs RNAZ Comparison

Compare BEEM & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

HOLD

Current Price

$1.13

Market Cap

28.6M

Sector

Technology

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$1.63

Market Cap

27.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEEM
RNAZ
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
27.9M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
BEEM
RNAZ
Price
$1.13
$1.63
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $3.50
N/A
AVG Volume (30 Days)
★ 294.4K
48.5K
Earning Date
04-09-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 40.77
N/A
EPS
★ N/A
N/A
Revenue
★ $28,236,000.00
N/A
Revenue This Year
$40.48
N/A
Revenue Next Year
$32.17
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.97
$1.58
52 Week High
$4.04
$20.99

Technical Indicators

Market Signals
Indicator
BEEM
RNAZ
Relative Strength Index (RSI) 34.20 30.35
Support Level $1.09 $1.58
Resistance Level $1.66 $9.37
Average True Range (ATR) 0.06 0.21
MACD -0.03 0.11
Stochastic Oscillator 1.52 8.81

Price Performance

Historical Comparison
BEEM
RNAZ

About BEEM Beam Global

Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: